Glucagon Gland: In-Depth Analysis of Peptide Product Composition
Abstract: Glucagon, secreted by pancreatic alpha cells, is a critical peptide hormone for glucose homeostasis. This analysis examines glucagon-based peptide product composition, comparing leading brands (e.g., Novo Nordisk, Eli Lilly) on purity, stability, and delivery systems. Market data (Grand View Research, 2024) projects a 7.8% CAGR for peptide therapeutics, driven by diabetes and obesity applications. Technical advantages include high specificity; limitations involve short half-life and cold-chain logistics. Product certifications (GMP, USP) and factory audits ensure quality. Selection criteria prioritize bioactivity, excipient compatibility, and regulatory compliance. Industry trends highlight synthetic analogs and dual-agonist innovations.